Corbus Pharmaceuticals Holdings Inc CRBP
NASDAQ · United States · Health Technology
$6.34-0.48 (-7.04%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -1.81 | -1.26 | -43.8% | $0 | — | +6.3%$9.57→$10.17 |
| Q1 2026 | 2026-05-12 | -1.23 | -1.22 | -0.8% | — | — | +10.1%$11.04→$12.15 |
| Q4 2025 | 2026-03-09 | -1.25 | -1.58 | +20.9% | — | — | +25.3%$8.01→$10.04 |
| Q3 2025 | 2025-11-12 | -1.90 | -1.71 | -11.1% | — | — | +6.2%$10.42→$11.07 |
| Q2 2025 | 2025-08-05 | -1.44 | -1.33 | -8.3% | — | — | — |
| Q1 2025 | 2025-05-06 | -1.39 | -1.07 | -29.9% | — | — | — |
| Q4 2024 | 2025-03-11 | -0.78 | -1.26 | +38.1% | — | — | — |
| Q2 2024 | 2024-08-06 | -0.90 | -1.19 | +24.4% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.